If phase 3 data replicates the Jastreboff phase 2 outcomes (24.2% weight loss sustained over 48 weeks) and achieves regulatory approval from the MHRA and EMA by 20272028, two pricing scenarios emerge: Scenario 1 (prescription approval): Retatrutide becomes a prescription-only medicine
GHK-Cu (2mg x 60 Capsules) (Copper Tripeptide) Typical dosages can range, but commonly its 2 capsules per serving, which can be taken with food
Service could not be better
An undated COA, a COA from the same company rather than an independent lab, or a COA that does not specify the batch number is insufficient
Biote NAD+ 1000 Benefits of NAD+ 300 & NAD+ 1000 For patients already optimizing hormones, sleep, and nutrition, NAD+ 300 & NAD+ 1000 help fill the gap when energy dips or recovery slows
The best approach depends on whether the goal is growth/maintenance or injury recovery